These findings suggest the participation of RIP140 in the maintenance of energy homeostasis by acting as an inhibitor of energy production and particularly point to RIP140 as a promising therapeutic target in the treatment of insulin resistance. This evidence concerns the gene NRIP1 and Insulin resistance.